The deletion of SphK1 in mice exacerbated the disease severity of experimental HUS, as evidenced primarily by a worsening of clinical presentation, and increased plasma cytokine and chemokine levels. The gene discussed is SPHK1; the disease is hemolytic-uremic syndrome.